DK0828717T3 - Fremgangsmåde til fremstilling af 3-haloalkyl-1H-pyrazol - Google Patents

Fremgangsmåde til fremstilling af 3-haloalkyl-1H-pyrazol

Info

Publication number
DK0828717T3
DK0828717T3 DK96920420T DK96920420T DK0828717T3 DK 0828717 T3 DK0828717 T3 DK 0828717T3 DK 96920420 T DK96920420 T DK 96920420T DK 96920420 T DK96920420 T DK 96920420T DK 0828717 T3 DK0828717 T3 DK 0828717T3
Authority
DK
Denmark
Prior art keywords
haloalkyl
pyrazole
preparation
pyrazoles
adoption
Prior art date
Application number
DK96920420T
Other languages
Danish (da)
English (en)
Inventor
Benxin Zhi
Murad Newaz
John J Talley
Stephen Bertenshaw
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Application granted granted Critical
Publication of DK0828717T3 publication Critical patent/DK0828717T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK96920420T 1995-05-25 1996-05-23 Fremgangsmåde til fremstilling af 3-haloalkyl-1H-pyrazol DK0828717T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44997595A 1995-05-25 1995-05-25
PCT/US1996/007506 WO1996037476A1 (en) 1995-05-25 1996-05-23 Method of preparing 3-haloalkyl-1h-pyrazoles

Publications (1)

Publication Number Publication Date
DK0828717T3 true DK0828717T3 (da) 2003-01-06

Family

ID=23786237

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96920420T DK0828717T3 (da) 1995-05-25 1996-05-23 Fremgangsmåde til fremstilling af 3-haloalkyl-1H-pyrazol

Country Status (20)

Country Link
US (2) US5892053A (cs)
EP (1) EP0828717B1 (cs)
JP (1) JP3996638B2 (cs)
KR (1) KR100444802B1 (cs)
CN (1) CN1174970C (cs)
AT (1) ATE223383T1 (cs)
AU (1) AU708964B2 (cs)
BR (1) BR9609043A (cs)
CA (1) CA2222138C (cs)
CZ (1) CZ292320B6 (cs)
DE (1) DE69623460T2 (cs)
DK (1) DK0828717T3 (cs)
ES (1) ES2182991T3 (cs)
NO (1) NO311130B1 (cs)
NZ (1) NZ308875A (cs)
PL (1) PL187410B1 (cs)
PT (1) PT828717E (cs)
RO (1) RO118200B1 (cs)
RU (2) RU2169143C2 (cs)
WO (1) WO1996037476A1 (cs)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6716991B1 (en) 1993-11-30 2004-04-06 G. D. Searle & Co. Process for preparing a substituted pyrazolyl benzenesulfonamide for the treatment of inflammation
US6492411B1 (en) * 1993-11-30 2002-12-10 G. D. Searle & Co. Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation
US5466823A (en) 1993-11-30 1995-11-14 G.D. Searle & Co. Substituted pyrazolyl benzenesulfonamides
US6525053B1 (en) 1997-08-22 2003-02-25 Abbott Laboratories Prostaglandin endoperoxide H synthase biosynthesis inhibitors
US6307047B1 (en) 1997-08-22 2001-10-23 Abbott Laboratories Prostaglandin endoperoxide H synthase biosynthesis inhibitors
ES2137138B1 (es) * 1998-05-29 2000-09-16 Esteve Labor Dr Derivados de pirazolinas, su preparacion y su aplicacion como medicamentos.
US6727238B2 (en) * 1998-06-11 2004-04-27 Pfizer Inc. Sulfonylbenzene compounds as anti-inflammatory/analgesic agents
US6294558B1 (en) 1999-05-31 2001-09-25 Pfizer Inc. Sulfonylbenzene compounds as anti-inflammatory/analgesic agents
SA99191255B1 (ar) 1998-11-30 2006-11-25 جي دي سيرل اند كو مركبات سيليكوكسيب celecoxib
EP1144383A1 (en) * 1999-01-14 2001-10-17 Merck Frosst Canada & Co. Synthesis of 4-[(5-substituted or unsubstituted phenyl)-3-substituted-1h-pyrazol-1-yl]benzenesulfonamides
CN1376146B (zh) * 1999-12-08 2011-04-06 法马西亚公司 提高了生物利用率的雪列柯西的固态形式
ATE283048T1 (de) * 1999-12-08 2004-12-15 Pharmacia Corp Cyclooxygenase-2 hemmer enthaltende zusammensetzungen mit schnellem wirkungseintritt
MY120279A (en) * 2000-05-26 2005-09-30 Pharmacia Corp Use of a celecoxib composition for fast pain relief
TR200001872A2 (tr) * 2000-06-26 2002-01-21 Fako �La�Lari A.� 4-[5-(4-Metilfenil-3-(triflorometil)-1H-pirazol-1-il] benzensulfonamit' in yeni kristal biçimi "Biçim I" ve bu ürünün üretilmesine ilişkin yöntem.
US20020128267A1 (en) * 2000-07-13 2002-09-12 Rebanta Bandyopadhyay Method of using COX-2 inhibitors in the treatment and prevention of ocular COX-2 mediated disorders
PE20020146A1 (es) * 2000-07-13 2002-03-31 Upjohn Co Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2)
US20030219461A1 (en) * 2000-09-12 2003-11-27 Britten Nancy J. Parenteral combination therapy for infective conditions
US7115565B2 (en) * 2001-01-18 2006-10-03 Pharmacia & Upjohn Company Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
PE20021017A1 (es) 2001-04-03 2002-11-24 Pharmacia Corp Composicion parenteral reconstituible
US20030161867A1 (en) * 2001-05-31 2003-08-28 Lu Guang Wei Skin-permeable selective cyclooxygenase-2 inhibitor composition
UA80682C2 (en) * 2001-08-06 2007-10-25 Pharmacia Corp Orally deliverable stabilized oral suspension formulation and process for the incresaing physical stability of thixotropic pharmaceutical composition
WO2003091221A1 (en) * 2002-04-25 2003-11-06 Generics [Uk] Limited Celecoxib forms
WO2004041243A2 (en) * 2002-05-13 2004-05-21 Pharmacia Corporation Stable amorphous celecoxib composite and process therefor
WO2003099794A1 (en) * 2002-05-24 2003-12-04 Pharmacia Corporation Synthesis of diaryl pyrazoles
JP2004115436A (ja) * 2002-09-26 2004-04-15 Nippon Nohyaku Co Ltd ピラゾール誘導体の製造方法
US20080153894A1 (en) * 2002-12-19 2008-06-26 Pharmacia Corporation Cyclooxygenase-2 inhibitor and antibacterial agent combination for intramammary treatment of mastitis
US20050009931A1 (en) * 2003-03-20 2005-01-13 Britten Nancy Jean Dispersible pharmaceutical composition for treatment of mastitis and otic disorders
US20050004098A1 (en) * 2003-03-20 2005-01-06 Britten Nancy Jean Dispersible formulation of an anti-inflammatory agent
CA2519125A1 (en) * 2003-03-20 2004-09-30 Pharmacia Corporation Dispersible formulation of an anti-inflammatory agent
US20040214753A1 (en) * 2003-03-20 2004-10-28 Britten Nancy Jean Dispersible pharmaceutical composition for treatment of mastitis and otic disorders
ES2257929B1 (es) * 2004-07-16 2007-05-01 Laboratorios Del Dr. Esteve, S.A. Derivados de pirazolina, procedimiento para su obtencion y utilizacion de los mismos como agentes terapeuticos.
CA2589167A1 (en) 2004-11-23 2006-06-01 Pliva Hrvatska D.O.O. Extended release pharmaceutical composition of celecoxib
WO2010095024A2 (en) 2009-02-20 2010-08-26 Aurobindo Pharma Limited An improved process for the preparation of celecoxib
WO2011055233A2 (en) 2009-11-03 2011-05-12 Actavis Group Ptc Ehf Improved process for preparing celecoxib polymorph
US20110213159A1 (en) * 2010-03-01 2011-09-01 Vamsee Krishna Muppidi Process for preparation of celecoxib crystalline form
EP2607358A4 (en) 2010-08-19 2014-01-29 Univ Tokyo NEW OMEGA-3 FATTY ACIDS RECOVERY-RESISTANT METABOLITE
CN102746231A (zh) * 2011-04-20 2012-10-24 天津药物研究院 塞来昔布制备工艺
CN103980201B (zh) * 2014-05-23 2016-02-10 苏州大学 一种含砜基的全取代吡唑的制备方法
CN110407683A (zh) * 2019-04-03 2019-11-05 湖南方盛制药股份有限公司 一种塞来昔布二酮中间体的制备方法
CN114292235B (zh) * 2021-12-29 2023-04-14 江苏天和制药有限公司 一种地拉考昔的制备和提纯方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA714221B (en) * 1970-07-10 1972-03-29 Astra Ab Insecticides
US3946057A (en) * 1972-05-03 1976-03-23 Union Carbide Corporation Preparation of metal complexes of 1,3-diketones
DE2429674A1 (de) * 1974-06-20 1976-01-08 Hoechst Ag Verfahren zur herstellung aromatischer 1,3-diketone
IL91382A (en) * 1988-09-01 1995-06-29 Orion Yhtymae Oy Alkenyl or arylmethylene-substituted beta-diketones their preparation and pharmaceutical compositions containing them
PH27357A (en) * 1989-09-22 1993-06-21 Fujisawa Pharmaceutical Co Pyrazole derivatives and pharmaceutical compositions comprising the same
US5344992A (en) * 1990-04-26 1994-09-06 Ciba-Geigy Corporation Process for the preparation of linear 1,3-diketones
KR0168056B1 (ko) * 1990-04-26 1999-03-20 베르너 발데크 선형 1,3-디케톤의 제조방법
IL104311A (en) * 1992-02-05 1997-07-13 Fujisawa Pharmaceutical Co Pyrazole derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
FR2701024B1 (fr) * 1993-02-01 1995-05-05 Rhone Poulenc Chimie Composant bétadicétonique pour additifs PVC, additif et PVC contenant ledit additif.
DE69422306T4 (de) * 1993-11-30 2000-09-07 G.D. Searle & Co., Chicago Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzündungen
US5466823A (en) * 1993-11-30 1995-11-14 G.D. Searle & Co. Substituted pyrazolyl benzenesulfonamides

Also Published As

Publication number Publication date
NO975387D0 (no) 1997-11-24
CN1190960A (zh) 1998-08-19
ES2182991T3 (es) 2003-03-16
RU2251543C2 (ru) 2005-05-10
RU2169143C2 (ru) 2001-06-20
US5910597A (en) 1999-06-08
CZ292320B6 (cs) 2003-09-17
US5892053A (en) 1999-04-06
PL187410B1 (pl) 2004-07-30
DE69623460T2 (de) 2003-02-27
JPH11505848A (ja) 1999-05-25
EP0828717B1 (en) 2002-09-04
AU708964B2 (en) 1999-08-19
NO311130B1 (no) 2001-10-15
EP0828717A1 (en) 1998-03-18
CN1174970C (zh) 2004-11-10
NZ308875A (en) 1999-08-30
CA2222138C (en) 2008-10-14
MX9709065A (es) 1998-03-31
NO975387L (no) 1997-12-17
PT828717E (pt) 2002-12-31
WO1996037476A1 (en) 1996-11-28
DE69623460D1 (de) 2002-10-10
KR100444802B1 (ko) 2004-12-17
RO118200B1 (ro) 2003-03-28
BR9609043A (pt) 1999-02-23
CZ368997A3 (cs) 1998-03-18
JP3996638B2 (ja) 2007-10-24
PL323492A1 (en) 1998-03-30
ATE223383T1 (de) 2002-09-15
CA2222138A1 (en) 1996-11-28
AU5873696A (en) 1996-12-11
KR19990021966A (ko) 1999-03-25

Similar Documents

Publication Publication Date Title
DK0828717T3 (da) Fremgangsmåde til fremstilling af 3-haloalkyl-1H-pyrazol
DK1007092T3 (da) En fremgangsmåde til inhibering af komplementaktivering via det alternative forlöb
NO892824D0 (no) Hoderem-anordning for gassmaske.
DE69006143D1 (de) Hochdruckgaszufuhrsystem.
NO913362D0 (no) Gassturbin for kraftproduksjon.
NO993247D0 (no) FremgangsmÕte for fremstilling av tolterodin
DK0542669T3 (da) Fremgangsmåde til fremstilling af pigmenter, især fluorescerende pigmenter.
EP0615949A3 (en) Device for the production of hydrogen.
CA2157905A1 (fr) Procede de purification des taxoides
DK0937055T3 (da) Fremgangsmåde til fremstilling af d,I-alfa-tocopherol
NO901536D0 (no) Fremgangsmaate ved desoxydasjon av vann, spesielt sjoevann.
FI960854L (fi) Menetelmä olefiinien polymeroimiseksi kaasufaasissa
DK0780446T3 (da) Fremgangsmåde til fremstilling af pigmenter
FI925869A7 (fi) Menetelmä, jolla voidaan viedä peptidi solulimaan
ES2185196T3 (es) Un procedimiento para la preparacion de tetraazamacrociclos.
FI974435A7 (fi) Menetelmä 2,4-diklooripyridiinien muuttamiseksi 2-aryylioksi-4-kloorip yridiineiksi
MX9708510A (es) Tetralinas.
DK0735043T3 (da) Fremgangsmåde til fremstilling af 2-substitueret 3,3-difluorfuran
DE69725713D1 (de) Spiro(cyclopent(b)indol-piperidine) und n-phenylhydrazon-zwischenprodukte zu deren herstellung, beide als acetylcholinesterase- und mao-inhibitoren
PT1064265E (pt) Sintese de 3-amino-2-cloro-4-metilpiridina a partir de malononitrilo e acetona
DK0704438T3 (da) Fremgangsmåde til fremstilling af 2-cyaniminothiazolidin
DK95391A (da) Fremgangsmaade til fremstilling af hydrogenholdig gas
GR1002949B (el) Φαρμακα
FI905857A0 (fi) Anordning foer genomtraengande av ledningar.
GR1001635B (el) Μέ?οδος παρασκευής 3-[2-(διμε?υλαμινο)-αι?υλο]-ν-με?υλο-1η-ινδόλης-5-με?ανοσουλφοναμίδης.